Aamal A. Al-Mutairi

According to our database, Aamal A. Al-Mutairi authored at least 3 papers between 2025 and 2026.

Collaborative distances:

• Dijkstra number of five.
• Erdős number of five.

2026

Design, synthesis, and integrated in silico analysis of novel difluoroboron curcumin analogues as potent inhibitors of the K562 leukemia cell line.

Tahseen A. Alsalim, Hamsa H. Al-Hujaj, Rehab G. Abood, Ahmed A. Majed, Aamal A. Al-Mutairi, Magdi E. A. Zaki, Sami A. Al-Hussain, Sobhi M. Gomha, Ahmed Elhenawy

J. Comput. Aided Mol. Des., December, 2026

2025

Fungal metabolite Ochratoxin A inhibits MrkD1P of multidrug-resistant Klebsiella pneumoniae: Integrated computational and in vitro validation.

Md Roqunuzzaman, Ariful Islam, Sumaiya Jahan Supti, Mahbub Hasan Rifat, Mohammad Saiful Islam, Ummay Habiba Ananna, Khalid Saifullah Tusher, Aamal A. Al-Mutairi, Magdi E. A. Zaki, Subir Sarker, Md. Eram Hosen

J. Comput. Aided Mol. Des., December, 2025

Computational screening of natural products as tryptophan 2,3-dioxygenase inhibitors: Insights from CNN-based QSAR, molecular docking, ADMET, and molecular dynamics simulations.

Yassir Boulaamane, Santiago Bolivar Avila, Juan Rosales Hurtado, Iman Touati, Badr-Edine Sadoq, Aamal A. Al-Mutairi, Ali Irfan, Sami A. Al-Hussain, Amal A. M. Maurady, Magdi E. A. Zaki

Comput. Biol. Medicine, 2025